These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12162918)

  • 1. Nodular Lymphocyte Predominant Hodgkin's Lymphoma Presenting as Severe Hypercalcaemia: A Case Report.
    Burney IA; Nirmala V; Al-Moundhri MS; Woodhouse NJ
    Sultan Qaboos Univ Med J; 2007 Dec; 7(3):247-51. PubMed ID: 21748111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte predominant Hodgkin's disease.
    Ekstrand BC; Horning SJ
    Curr Oncol Rep; 2002 Sep; 4(5):424-33. PubMed ID: 12162918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
    von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
    Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
    Franklin J; Tesch H; Hansmann ML; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S39-44. PubMed ID: 9926236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
    Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
    Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma.
    van den Berg A; Maggio E; Diepstra A; de Jong D; van Krieken J; Poppema S
    Blood; 2002 Feb; 99(4):1492-4. PubMed ID: 11830507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab.
    Natkunam Y; Stanton TS; Warnke RA; Horning SJ
    Clin Lymphoma; 2001 Dec; 2(3):185-7. PubMed ID: 11779297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis.
    Ohno T; Huang JZ; Wu G; Park KH; Weisenburger DD; Chan WC
    Am J Clin Pathol; 2001 Oct; 116(4):506-11. PubMed ID: 11601135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
    Kirchner EM; Ebsen M; Kirchner J; Theegarten D; Voigtmann R
    Ann Oncol; 2001 Aug; 12(8):1169-71. PubMed ID: 11583202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced-stage, chemorefractory lymphocyte-predominant Hodgkin's disease: long-term follow-up of allografting and monoclonal antibody therapy.
    Lush RJ; Jones SG; Haynes AP
    Br J Haematol; 2001 Sep; 114(3):734-5. PubMed ID: 11553009
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonal identity of nodular lymphocyte-predominant Hodgkin's disease and T-cell-rich B-cell lymphoma.
    Shimodaira S; Hidaka E; Katsuyama T
    N Engl J Med; 2000 Oct; 343(15):1124-5. PubMed ID: 11032527
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.